Karyopharm names new head of investor relations

– elhan webb, cfa, formerly of rubius therapeutics and radius health, appointed as senior vice president of investor relations – – webb brings more than 20 years of diverse international experience across investor relations, business development, investment analysis and portfolio management in the healthcare and biotechnology fields – newton, mass., march 14, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of elhan webb as senior vice president of investor relations.
KPTI Ratings Summary
KPTI Quant Ranking